Novo Nordisk presents 2030 goals, shares slump
21/09/2026 09:31
BUZZ-Novo Nordisk presents 2030 goals, shares slump ** Shares in Novo Nordisk NOVOb.CO fall 6% after the Wegovy maker posted its strategic ambitions for 2030 ahead of its Capital Markets Day
** Novo says it targets to deliver pipeline sales of more than 150 billion Danish crowns ($23 billion) by 2035 and to increase its obesity customers 10 times
** But Nordnet analyst Per Hansen says the stock falls as there is no significant short-term news
** Shares are at the lowest level since April, falling 19% year-to-date
($1 = 6.5138 Danish crowns)
(Reporting by Boleslaw Lasocki)
Recent news on Novo Nordisk A/S
See all newsFocus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Factbox: Anthropic's public benefit fund and how it compares with other big philanthropic efforts
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals